Mitochondrial inflexibility ignites tumor immunogenicity in postoperative glioblastoma

Cellular and molecular heterogeneity contributes to the insufficient immunogenicity of glioblastoma multiforme (GBM), a lethal malignancy characterized by post-resection relapse, ultimately leading to limited immune cell infiltration. Here, we report a strategy to boost tumor immunity by activating...

Full description

Saved in:
Bibliographic Details
Published inNature communications Vol. 16; no. 1; pp. 6946 - 15
Main Authors Cheng, Lulu, Fang, Zezheng, Wang, Junpeng, Xi, Kaiyan, Zhang, Yi, Feng, Fan, Yu, Le, Santiago, Myla, Wang, Jingjing, Wu, Zimei, Wang, Kang-nan, Daubon, Thomas, Ni, Shilei, Zhang, Yanrong, Zhang, Yulin
Format Journal Article
LanguageEnglish
Published London Nature Publishing Group UK 28.07.2025
Nature Publishing Group
Nature Portfolio
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Cellular and molecular heterogeneity contributes to the insufficient immunogenicity of glioblastoma multiforme (GBM), a lethal malignancy characterized by post-resection relapse, ultimately leading to limited immune cell infiltration. Here, we report a strategy to boost tumor immunity by activating the endogenous cGAS-STING signaling pathway through in-situ manipulation of the mitochondrial electron transport chain (ETC), thereby augmenting the immune responsiveness of GBM. Under white light irradiation, the synthetic butterfly-shaped photosensitizer B-TTPy disrupts the mitochondrial ETC by producing excessive reactive oxygen species. Synergistically, inhibition of checkpoint kinase 1 amplifies ETC dysfunction, thus enhancing the cytotoxicity of B-TTPy against tumor cells. Our results demonstrate that the in-house-customized Mitochondrial Electron Alteration Nanoparticles in Glioblastoma (MEANING) efficiently activate innate and adaptive immune response by recruiting antigen-presenting cells and cytotoxic T cells to the surgical margin. Moreover, biodegradable hydrogel-medicated surgical cavity treatment with MEANING can reshape the immunosuppressive tumor microenvironment and eliminate residual GBM cells. In sum, our findings establish a local immune activation approach for GBM, to prevent postoperative tumor recurrence and identify ETC blockade as a promising therapeutic strategy for low-immunogenic tumors. Cellular and molecular heterogeneity contributes to the insufficient immunogenicity of glioblastoma (GBM), ultimately leading to limited immune cell infiltration. Here this group reports a GBM therapeutic strategy by activating endogenous cGAS-STING signaling pathway by modulating mitochondrial electron transport chain thereby augmenting the immune responsiveness of GBM.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ISSN:2041-1723
2041-1723
DOI:10.1038/s41467-025-62244-5